Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Handbook of Experimental Pharmacology
|
April 7, 2006
Protection of endothelial function
L E Spieker, T F Lüscher
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis
L E Spieker, T F Lüscher, G Noll
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 20, 2004
Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders
L E Spieker, G Noll, T F Lüscher
Handbook of Experimental Pharmacology
|
September 27, 2006
The vascular endothelium in hypertension
L E Spieker, A J Flammer, T F Lüscher
Journal of Cardiovascular Pharmacology
|
March 10, 2000
Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels
L E Spieker, G Noll, M Hannak, et al.
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitors
T F Lüscher, L E Spieker, G Noll, et al.
Schweizerische Medizinische Wochenschrift
|
March 7, 1998
[Sympathy and heartache: new information on the sympathetic nervous system]
L E Spieker, C Binggeli, T F Lüscher, et al.
Heart Failure Reviews
|
July 12, 2001
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
L E Spieker, G Noll, F T Ruschitzka, et al.
Journal of the American College of Cardiology
|
May 10, 2001
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
L E Spieker, G Noll, F T Ruschitzka, et al.
Journal of the American College of Cardiology
|
July 18, 2000
Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans
L E Spieker, R Corti, C Binggeli, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Handbook of Experimental Pharmacology
|
April 7, 2006
Protection of endothelial function
L E Spieker, T F Lüscher
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Current strategies and perspectives for correcting endothelial dysfunction in atherosclerosis
L E Spieker, T F Lüscher, G Noll
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 20, 2004
Therapeutic potential for endothelin receptor antagonists in cardiovascular disorders
L E Spieker, G Noll, T F Lüscher
Handbook of Experimental Pharmacology
|
September 27, 2006
The vascular endothelium in hypertension
L E Spieker, A J Flammer, T F Lüscher
Journal of Cardiovascular Pharmacology
|
March 10, 2000
Efficacy and tolerability of fluvastatin and bezafibrate in patients with hyperlipidemia and persistently high triglyceride levels
L E Spieker, G Noll, M Hannak, et al.
Journal of Cardiovascular Pharmacology
|
January 29, 2002
Vascular effects of newer cardiovascular drugs: focus on nebivolol and ACE-inhibitors
T F Lüscher, L E Spieker, G Noll, et al.
Schweizerische Medizinische Wochenschrift
|
March 7, 1998
[Sympathy and heartache: new information on the sympathetic nervous system]
L E Spieker, C Binggeli, T F Lüscher, et al.
Heart Failure Reviews
|
July 12, 2001
Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
L E Spieker, G Noll, F T Ruschitzka, et al.
Journal of the American College of Cardiology
|
May 10, 2001
Endothelin receptor antagonists in congestive heart failure: a new therapeutic principle for the future?
L E Spieker, G Noll, F T Ruschitzka, et al.
Journal of the American College of Cardiology
|
July 18, 2000
Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans
L E Spieker, R Corti, C Binggeli, et al.
Page
of 2